Indian billionaires buy foreign companies as growth slows at home – MyJoyOnline
In late April, India's Sun Pharmaceuticals agreed to pay $11.75bn (£8.59bn) to acquire New York-listed women's health and biosimilars firm Organon & Co. It marked the biggest overseas acquisition by an Indian company in nearly two decades and followed a string of high-profile international deals by Indian firms in recent months. These include Tata Motors' $4.4bn acquisition of Turin-based vehicle…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
